Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study.
- Published in:
- Drugs, 2022, v. 82, n. 18, p. 1717, doi. 10.1007/s40265-022-01816-x
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2022 AND VI 82 AND IP 18
Results: 9
1
2
Authors' Reply to Denning: Comment on: "Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries".
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
3
Acknowledgement to Referees.
- Published in:
- Drugs, 2022, v. 82, n. 18, p. 1691, doi. 10.1007/s40265-022-01815-y
- Publication type:
- Article
4
The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis.
- Published in:
- Drugs, 2022, v. 82, n. 18, p. 1695, doi. 10.1007/s40265-022-01817-w
- By:
- Publication type:
- Article
5
Dorzagliatin: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 18, p. 1745, doi. 10.1007/s40265-022-01813-0
- By:
- Publication type:
- Article
6
Correction: Teprotumumab: A Review in Thyroid Eye Disease.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
7
Comment on: "Global Consumption Trend of Antifungal Agents in Humans from 2008 to 2018: Data from 65 Middle‐ and High‐Income Countries".
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
8
Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria.
- Published in:
- Drugs, 2022, v. 82, n. 18, p. 1727, doi. 10.1007/s40265-022-01809-w
- By:
- Publication type:
- Article
9
Futibatinib: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 18, p. 1737, doi. 10.1007/s40265-022-01806-z
- By:
- Publication type:
- Article